France Oral Contraceptives Market Insights Forecasts to 2033

• The France Oral Contraceptives Market Size was valued at USD 505.1 Million in 2023.
• The Market is growing at a CAGR of 4.91% from 2023 to 2033
• The France Oral Contraceptives Market Size is expected to reach USD 815.5 Million by 2033

The France Oral Contraceptives Market is anticipated to exceed USD 815.5 Million by 2033, growing at a CAGR of 4.91% from 2023 to 2033. The growing awareness of the advantages of oral contraceptives, increasing the proportion of women working, increasing the number of sexually transmitted diseases (STIs), increasing the usage of reversible long-acting contraception (LARCs), and increasing the number of internet pharmacies are driving the growth of the oral contraceptives market in the France.     

Market Overview

Oral contraceptives, also known as birth control tablets or simply "the pill", are typically made of synthetic hormones, an estrogen and progestin combination, or just progestin alone. These hormones work together to limit ovulation and the ovary’s ability to release eggs. They also thicken cervical mucus, which makes it harder for sperm to enter the uterus, and thin the uterine lining, which makes it less sensitive to implantation. In both rural and urban regions, women are becoming more knowledgeable about family planning and contraception as a result of government efforts to manage population growth in the country. France is one of the leading nations in terms of access to contraception and has the highest birth rate in Europe. The development of pharmaceuticals has significantly improved women's reproductive health by providing them with a practical and safe means of contraceptives.

Report Coverage

This research report categorizes the market for the France oral contraceptives market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the France oral contraceptives market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the France oral contraceptives market.

Driving Factors

The growing awareness about the advantages of oral contraceptives and growing cases of sexually transmitted diseases (STIs) are driving the market growth. The launch of initiatives meant to reduce unwanted pregnancies and related healthcare costs as well as increase user awareness are fueling the market expansion of oral contraceptives. Furthermore, it is projected that the increase in unintended pregnancies promotes the market's growth. In addition, the rising use of reversible long-acting contraception (LARCs), the proportion of working women, and e-commerce are all factors responsible for propelling the market.

Restraining Factors

The inaccessibility of oral contraceptives in underdeveloped and low-income regions due to their high cost is restraining the market growth. Further, the side effects and health concerns associated with oral contraceptives hamper the market growth.

Market Segmentation

The France Oral Contraceptives Market share is classified into type and distribution channel.

• The combination pills segment dominates the market with the largest market share through the forecast period.

The France oral contraceptives market is segmented by type into combination pills and progestin-only pills. Among these, the combination pills segment dominates the market with the largest market share through the forecast period. Progesterone and estrogen are the two hormones found in combined contraceptive pills, which are an effective form of reversible contraception with minimal adverse effects. Some of the benefits of combination contraceptive tablets include improved acne control, alleviation from premenstrual syndrome, and better control of the monthly menstrual cycle.

• The retail pharmacy segment dominates the France oral contraceptives market with the largest market share in 2023.       

Based on the distribution channel, the France oral contraceptives market is divided into hospital pharmacy, retail pharmacy, clinics, online channel, public channel & NGO, and others. Among these, the retail pharmacy segment dominates the France oral contraceptives market with the largest market share in 2023. The increasing sales of OTC contraceptives as well as rising public awareness along with knowledge about different types of contraception are driving the market. There is a collaboration of key companies with regional and local distributors for escalating the market growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the France oral contraceptives market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Allergan plc
• Johnson & Johnson Services, Inc.
• Bayer AG
• Merck & Co., Inc.
• Pfizer, Inc.
• Teva Pharmaceutical Industries Ltd.
• Mankind Pharma Ltd.
• Piramal Enterprises
• Syzygy Healthcare LLC
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at France, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the France Oral Contraceptives Market based on the below-mentioned segments:

France Oral Contraceptives Market, By Type

• Combination Pills
• Progestin-only Pills

France Oral Contraceptives Market, By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Clinics
• Online Channel
• Public Channel & NGO
• Others